Invokana Lawsuit Filings Reveal the Heart Attack Risks Associated With Using the Drug

April 19, 2016 – – TheProductLawyers.com comments on results of clinical trials that currently concern many. The clinical trials were conducted on Invokana – a type-2 diabetes drug – that was released in 2013 to the market after receiving the go ahead from the U.S FDA (Food and Drug Administration). According to the results of the clinical tests, the new generation drug has shown major heightened heart attack risks among patients during the early thirty days of their treatment.

When clinical tests were performed on Invokana, the results were quite alarming. A number of patients utilizing the drug suddenly suffered from strokes or heart attacks within the maiden thirty days of using the drug. After the lapse of 30 days, the risk factors unexplainably and suddenly leveled out. At the time, researchers could not pinpoint exactly what informed the situation. However, for quite some time now, it has been established that diabetes drugs might escalate cholesterol levels in patients that in turn causes heart problems.

The United States Food and Drug Administration asked Johnson & Johnson to perform 5 post-marketing studies that include a clinical trial to ascertain more definitely whether the drug increases the risks. The FDA also needs patients that use the drug to remain highly vigilant as they remain on the lookout for symptoms within the first thirty days of treatment. Patients that notice any symptom are advised to seek immediate medical attention.

Banville Law attorneys are highly committed to ensuring the public remains informed of the important information that is released on Invokana as well as other similar drugs. To make sure this objective is accomplished, the attorneys support TheProductLawyers.com, which is a resource website full of important and current information for patients. Moreover, Banville attorneys wish to see to it that every user of Invokana or any other SGLT2 class inhibitor drug evaluates his or her rights fully in the event they suffer from health conditions related to using the drug. Affected individuals may be entitled to compensation. Currently, Banville attorneys are providing complimentary legal consultations to help patients pursue justice.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009396